Abstract | BACKGROUND: OBJECTIVES: STUDY DESIGN: We analyzed 1998-2015 data from the Slone Epidemiology Center Birth Defects Study, a multi-site, case-control study. Mothers were interviewed to identify sociodemographic factors, behaviors, and exposures during pregnancy. Periconceptional NSAID use was defined as use of aspirin, ibuprofen, naproxen, or COX2 inhibitors within the month before or after the last menstrual period. Logistic regression models were used to estimate adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for NSAID use, adjusted for study center and race/ethnicity stratified by average daily folic acid intake above ("high FA") or below ("low FA") 400 mcg/day. RESULTS: We compared mothers of 267 infants with spina bifida to mothers of 6,233 nonmalformed controls. Among control mothers, 20% used NSAIDS periconceptionally (16% ibuprofen, 4% aspirin, 3% naproxen, and <1% COX-2 inhibitors). For any NSAID use, the aORs among low FA and high FA women were 1.70 (95% CI [1.13, 2.57]) and 1.09 (95% CI [0.69, 1.71]), respectively. CONCLUSIONS: We observed a small increase in the risk for spina bifida among infants born to women who used NSAIDs periconceptionally, but this risk was limited to those who had inadequate folic acid intake.
|
Authors | Daina B Esposito, Samantha E Parker, Allen A Mitchell, Sarah C Tinker, Martha M Werler |
Journal | Birth defects research
(Birth Defects Res)
Vol. 113
Issue 17
Pg. 1257-1266
(10 15 2021)
ISSN: 2472-1727 [Electronic] United States |
PMID | 34346174
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Copyright | © 2021 Wiley Periodicals LLC. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Pharmaceutical Preparations
- Folic Acid
|
Topics |
- Anti-Inflammatory Agents, Non-Steroidal
(adverse effects)
- Case-Control Studies
- Female
- Folic Acid
- Humans
- Infant
- Pharmaceutical Preparations
- Pregnancy
- Spinal Dysraphism
(epidemiology, etiology, prevention & control)
|